Jacobio Pharmaceuticals Co., Ltd.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jacobio Pharmaceuticals Co., Ltd..The latest application filed is for "kras mutant protein inhibitors".
- Jacobio Pharmaceuticals Co., Ltd. - Beijing CN
- JACOBIO PHARMACEUTICALS CO., LTD - Beijing CN
- Jacobio Pharmaceuticals Co., Ltd. -
| Patent | Date |
|---|---|
| Heterocyclic compounds useful as aurora a selective inhibitors Grant 11,384,066 - Cheng , et al. July 12, 2 | 2022-07-12 |
| KRAS mutant protein inhibitors Grant 11,384,087 - Li , et al. July 12, 2 | 2022-07-12 |
| KRAS mutant protein inhibitors App 20220213109 - LI; Amin ; et al. | 2022-07-07 |
| KRAS mutant protein inhibitors Grant 11,345,701 - Li , et al. May 31, 2 | 2022-05-31 |
| Fused Ring Derivative Used As Fgfr4 Inhibitor App 20220119386 - YANG; Hongwei ; et al. | 2022-04-21 |
| Tricyclic Compounds App 20220119390 - FANG; Haiquan ; et al. | 2022-04-21 |
| Binding Molecule Specific For Cd73 And Use Of Binding Molecule App 20220064322 - LIU; Qinghao ; et al. | 2022-03-03 |
| Binding Molecule Specific For Lif And Use Thereof App 20210403582 - LIU; Qinghao ; et al. | 2021-12-30 |
| Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors App 20210393623 - Han; Huifeng ; et al. | 2021-12-23 |
| KRAS mutant protein inhibitors Grant 11,180,506 - Li , et al. November 23, 2 | 2021-11-23 |
| Binding molecule specific for CD73 and use of binding molecule Grant 11,174,319 - Liu , et al. November 16, 2 | 2021-11-16 |
| KRAS mutant protein inhibitors Grant 11,161,847 - Li , et al. November 2, 2 | 2021-11-02 |
| Fused ring derivative used as FGFR4 inhibitor Grant 11,136,320 - Yang , et al. October 5, 2 | 2021-10-05 |
| KRAS Mutant Protein Inhibitors App 20210300920 - LI; Amin ; et al. | 2021-09-30 |
| KRAS mutant protein inhibitors App 20210292331 - LI; Amin ; et al. | 2021-09-23 |
| Fused Ring Derivative Used As Fgfr4 Inhibitor App 20210269442 - YANG; Hongwei ; et al. | 2021-09-02 |
| Binding Molecule Specific For Cd73 And Use Of Binding Molecule App 20210253730 - LIU; Qinghao ; et al. | 2021-08-19 |
| Tricyclic Compounds App 20210179617 - FANG; Haiquan ; et al. | 2021-06-17 |
| Fused Ring Derivative Used As Fgfr4 Inhibitor App 20210163478 - YANG; Hongwei ; et al. | 2021-06-03 |
| Heterocyclic derivatives useful as SHP2 inhibitors Grant 10,988,466 - Ma , et al. April 27, 2 | 2021-04-27 |
| Kras Mutant Protein Inhibitors App 20210094919 - LI; Amin ; et al. | 2021-04-01 |
| Kras Mutant Protein Inhibitors App 20210040089 - GAO; Panliang ; et al. | 2021-02-11 |
| Novel Heterocyclic Derivatives Useful As Shp2 Inhibitors App 20200392128 - Ma; Cunbo ; et al. | 2020-12-17 |
| Heterocyclic ring derivatives useful as SHP2 inhibitors Grant 10,858,359 - Ma , et al. December 8, 2 | 2020-12-08 |
| Novel Heterocyclic Ring Derivatives Useful As Shp2 Inhibitors App 20190127378 - MA; Cunbo ; et al. | 2019-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 